{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:26:35Z","timestamp":1791026795619,"version":"4.1.0"},"reference-count":26,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T00:00:00Z","timestamp":1047340800000},"content-version":"vor","delay-in-days":38,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Dermatology"],"published-print":{"date-parts":[[2003,2]]},"abstract":"<jats:p><jats:bold>Abstract:<\/jats:bold> Gene therapy of large genes (e.g. plectin and collagen genes) is hampered by size limitations for insertions of the currently used viral vectors. To reduce the size of these insertions spliceosome\u2010mediated RNA <jats:italic>trans<\/jats:italic>\u2010splicing (SMaRT\u2122), which provides intron\u2010specific gene\u2010correction at the pre\u2010RNA level, can be an alternative approach. To test its applicability in skin gene therapy, SMaRT\u2122 was used in the context of the 4003delTC mutation in the collagen XVII gene (<jats:italic>COL17A1<\/jats:italic>) causing generalized atrophic benign junctional epidermolysis bullosa. A \u03b2\u2010galactosidase (\u03b2\u2010gal) <jats:italic>trans<\/jats:italic>\u2010splicing assay system was established using intron 51 of <jats:italic>COL17A1<\/jats:italic> as the target for <jats:italic>trans<\/jats:italic>\u2010splicing. In this system, intron 51 is flanked by the 5\u2032exon and the 3\u2032exon of the \u03b2\u2010gal gene, the latter containing two in\u2010frame stop codons. Cotransfection of a pre\u2010<jats:italic>trans<\/jats:italic>\u2010splicing molecule consisting of the binding domain of intron 51 and the 3\u2032exon of \u03b2\u2010gal without the stop codons resulted in a 300\u2010fold increase of \u03b2\u2010gal activity compared to controls. A 2\u20133\u2010fold increase in efficiency was obtained through an elongation of the binding domains. Replacement of the complete 3\u2032end of the <jats:italic>COL17A1<\/jats:italic> gene was shown using a collagen XVII mini\u2010gene construct. The \u03b2\u2010gal assay was used in human keratinocytes to evaluate the influence of a keratinocyte\u2010specific spliceosome background. Reverse transcription polymerase chain reaction and \u03b2\u2010gal activity assay showed functional correction of the stop\u2010codons in cultured human keratinocytes and in an immortalized GABEB cell line harbouring the 4003delTC mutation. These results demonstrate that SMaRT\u2122 is feasible in a keratinocyte\u2010specific context and therefore may be applied in skin gene therapy.<\/jats:p>","DOI":"10.1034\/j.1600-0625.2003.120105.x","type":"journal-article","created":{"date-parts":[[2003,12,22]],"date-time":"2003-12-22T09:00:35Z","timestamp":1072083635000},"page":"37-46","source":"Crossref","is-referenced-by-count":52,"title":["Development of spliceosome\u2010mediated RNA trans\u2010splicing (SMaRT\u2122) for the correction of inherited skin diseases"],"prefix":"10.1111","volume":"12","author":[{"given":"G.","family":"Dallinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Puttaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.\u2003G.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.\u2003B.","family":"Yancey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Klausegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Hintner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.\u2003W.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,3,11]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1996.7.18-2247"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1196-1263"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1998.9.9-1359"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3300730"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3300809"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/aja.1001970404"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.1.219"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/6986"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301307"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1006\/mthe.2001.0426"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.20.8020"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2438771"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.280.5369.1593"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0997-902"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0593-62"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.10.14.1724"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1982.01650180009008"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12345821"},{"key":"e_1_2_7_20_2","first-page":"87","article-title":"Generalized atrophic benign epidermolysis bullosa","volume":"13","author":"Darling T N","year":"1997","journal-title":"Adv Dermatol"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.65.070196.002055"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.9.9.2069"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1089\/104303400750035807"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-56441-3_7"},{"key":"e_1_2_7_25_2","doi-asserted-by":"crossref","first-page":"C341","DOI":"10.1152\/ajpcell.1996.270.1.C341","article-title":"Biosynthetic and growth abnormalities are associated with high\u2010level expression of CFTR in heterologous cells","volume":"270","author":"Schiavi S C","year":"1996","journal-title":"Am J Physiol"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81894-2"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/71901"}],"container-title":["Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0625.2003.120105.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1600-0625.2003.120105.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T23:49:45Z","timestamp":1697240985000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1600-0625.2003.120105.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,2]]}},"alternative-id":["10.1034\/j.1600-0625.2003.120105.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1600-0625.2003.120105.x","archive":["Portico"],"relation":{},"ISSN":["0906-6705","1600-0625"],"issn-type":[{"value":"0906-6705","type":"print"},{"value":"1600-0625","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2]]}}}